Market Leadership Geistlich is the global leader in regenerative dentistry and biological bone and cartilage regeneration, indicating a strong market presence and brand trust that can be leveraged to expand product offerings and cross-sell medical devices and drugs.

Expansion Activities Recent investments in expanding manufacturing facilities in Switzerland demonstrate capacity growth and potential for increased production volume, offering opportunities to supply raw materials, equipment, and support services.

Regulatory Success FDA clearance of new particulate collagen and strategic partnerships with companies like StimLabs point to ongoing product innovation and market expansion in the US, presenting possibilities to collaborate on new biomaterials and medical devices.

Strategic Divestments Geistlich’s recent asset sales and divestments suggest a focus on core competencies, which could open doors for business development professionals to offer complementary solutions or technology licensing in the regenerative medicine sector.

Research & Development Continued investment in scientific research and launching of projects like MEFISTO highlight a commitment to innovation, creating opportunities for partnerships in clinical research, advanced biomaterials, and technology development.